Suzanne T. Szak, Ph.D. - Publications

Affiliations: 
2000 Vanderbilt University, Nashville, TN 
Area:
Biochemistry

3/20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2001 Szak ST, Mays D, Pietenpol JA. Kinetics of p53 binding to promoter sites in vivo. Molecular and Cellular Biology. 21: 3375-86. PMID 11313463 DOI: 10.1128/Mcb.21.10.3375-3386.2001  0.621
2000 Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Molecular and Cellular Biology. 20: 4210-23. PMID 10825186 DOI: 10.1128/Mcb.20.12.4210-4223.2000  0.341
1999 Szak ST, Pietenpol JA. High affinity insertion/deletion lesion binding by p53. Evidence for a role of the p53 central domain. The Journal of Biological Chemistry. 274: 3904-9. PMID 9920946 DOI: 10.1074/Jbc.274.6.3904  0.566
Low-probability matches (unlikely to be authored by this person)
2018 Mullenbrock S, Liu F, Szak S, Hronowski X, Gao B, Juhasz P, Sun C, Liu M, McLaughlin H, Xiao Q, Feghali-Bostwick C, Zheng TS. Systems Analysis of Transcriptomic and Proteomic Profiles Identifies Novel Regulation of Fibrotic Programs by miRNAs in Pulmonary Fibrosis Fibroblasts. Genes. 9. PMID 30501089 DOI: 10.3390/Genes9120588  0.161
2013 Demarest SJ, Gardner J, Vendel MC, Ailor E, Szak S, Huang F, Doern A, Tan X, Yang W, Grueneberg DA, Richards EJ, Endege WO, Harlow E, Koopman LA. Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines. Biochemistry. 52: 3102-18. PMID 23570341 DOI: 10.1021/bi301588c  0.16
2008 Sun C, Orozco O, Olson DL, Choi E, Garber E, Tizard R, Szak S, Sanicola M, Carulli JP. CRIPTO3, a presumed pseudogene, is expressed in cancer. Biochemical and Biophysical Research Communications. 377: 215-20. PMID 18835250 DOI: 10.1016/j.bbrc.2008.09.113  0.143
2017 Dang LTH, Aburatani T, Marsh GA, Johnson BG, Alimperti S, Yoon CJ, Huang A, Szak S, Nakagawa N, Gomez I, Ren S, Read SK, Sparages C, Aplin AC, Nicosia RF, et al. Hyperactive FOXO1 results in lack of tip stalk identity and deficient microvascular regeneration during kidney injury. Biomaterials. 141: 314-329. PMID 28711779 DOI: 10.1016/J.Biomaterials.2017.07.010  0.128
2004 Han JS, Szak ST, Boeke JD. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature. 429: 268-74. PMID 15152245 DOI: 10.1038/Nature02536  0.118
2015 Nakagawa N, Xin C, Roach AM, Naiman N, Shankland SJ, Ligresti G, Ren S, Szak S, Gomez IG, Duffield JS. Dicer1 activity in the stromal compartment regulates nephron differentiation and vascular patterning during mammalian kidney organogenesis. Kidney International. 87: 1125-40. PMID 25651362 DOI: 10.1038/ki.2014.406  0.081
2013 Hosur R, Szak S, Thai A, Allaire N, Bienkowska J. ProbeSelect: selecting differentially expressed probes in transcriptional profile data. Bioinformatics (Oxford, England). 30: 574-5. PMID 24336808 DOI: 10.1093/bioinformatics/btt720  0.075
2002 Symer DE, Connelly C, Szak ST, Caputo EM, Cost GJ, Parmigiani G, Boeke JD. Human l1 retrotransposition is associated with genetic instability in vivo. Cell. 110: 327-38. PMID 12176320 DOI: 10.1016/S0092-8674(02)00839-5  0.072
2002 Szak ST, Pickeral OK, Makalowski W, Boguski MS, Landsman D, Boeke JD. Molecular archeology of L1 insertions in the human genome. Genome Biology. 3: research0052. PMID 12372140 DOI: 10.1186/Gb-2002-3-10-Research0052  0.066
2003 Szak ST, Pickeral OK, Landsman D, Boeke JD. Identifying related L1 retrotransposons by analyzing 3' transduced sequences. Genome Biology. 4: R30. PMID 12734010 DOI: 10.1186/Gb-2003-4-5-R30  0.062
2019 Crotti A, Sait HR, McAvoy KM, Estrada K, Ergun A, Szak S, Marsh G, Jandreski L, Peterson M, Reynolds TL, Dalkilic-Liddle I, Cameron A, Cahir-McFarland E, Ransohoff RM. BIN1 favors the spreading of Tau via extracellular vesicles. Scientific Reports. 9: 9477. PMID 31263146 DOI: 10.1038/s41598-019-45676-0  0.055
2011 Kawashima R, Kawamura YI, Oshio T, Son A, Yamazaki M, Hagiwara T, Okada T, Inagaki-Ohara K, Wu P, Szak S, Kawamura YJ, Konishi F, Miyake O, Yano H, Saito Y, et al. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis. Gastroenterology. 141: 2119-2129.e8. PMID 21893119 DOI: 10.1053/j.gastro.2011.08.040  0.055
2021 Wipke BT, Hoepner R, Strassburger-Krogias K, Thomas AM, Gianni D, Szak S, Brennan MS, Pistor M, Gold R, Chan A, Scannevin RH. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33468560 DOI: 10.1212/NXI.0000000000000950  0.04
2016 Gomez IG, Roach AM, Nakagawa N, Amatucci A, Johnson BG, Dunn K, Kelly MC, Karaca G, Zheng TS, Szak S, Peppiatt-Wildman CM, Burkly LC, Duffield JS. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease. Journal of the American Society of Nephrology : Jasn. PMID 27026366 DOI: 10.1681/ASN.2015111227  0.04
2020 Calabresi PA, Arnold DL, Sangurdekar D, Singh CM, Altincatal A, de Moor C, Engle B, Goyal J, Deykin A, Szak S, Kieseier BC, Rudick RA, Plavina T. Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520972573. PMID 33307998 DOI: 10.1177/1352458520972573  0.023
2020 Plavina T, Singh CM, Sangurdekar D, de Moor C, Engle B, Gafson A, Goyal J, Fisher E, Szak S, Kinkel RP, Sandrock AW, Su R, Kieseier BC, Rudick RA. Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode. Jama Network Open. 3: e2016278. PMID 33151313 DOI: 10.1001/jamanetworkopen.2020.16278  0.02
2018 Ranger A, Ray S, Szak S, Dearth A, Allaire N, Murray R, Gardner R, Cadavid D, Mi S. Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e417. PMID 29259995 DOI: 10.1212/NXI.0000000000000417  0.02
Hide low-probability matches.